Pfizer and Astrazeneca mark the death of Latin America

The vacancies of the pharmaceuticals Pfizer and Astrazeneca are, at the moment, being chosen by at least 11 Latin American countries, in front of a large group that hopes to launch the Covax mechanism, and other goblins who opted for the Russian Sputnik V o por china Sinovac.

The region, with more than 16.7 million people in contact, has high levels of infection, with Brazil having 8.9 million cases, which raises the urgency of immunization next to the mayor on the part of the population.

THE PIONEERS

A United States has unveiled a global health package for evacuation, the first aircraft loaded with Pfizer antigens for Latin Americans on December 23 in Mexico, which consists of 34.4 million doses.

The Mexican plan, which was launched one day later, has progressively yielded a total of 624,105 doses and only 28,715 people received the second injection needed to prevent it from becoming biological.

Gobierno’s objective is inoculated before the end of the year for all health personnel, starting in February with the seniors and in 2022 has injected free of charge into the 126 million Mexicans using, in addition to the Pfizer preparation, 77.4 million of the dose which negotiated with the British AstraZeneca, 35 million with the Chinese CanSino and 24 million from the Russian Sputnik V.

CHILE, COSTA RICA AND PANAMÁ HACEN LO SUYO

Another of the Latin American pioneers in the munitions system in Chile, which also opted for Pfizer, of which 26 had 56,549 people had received at least one dose and in that case 10,000 doses.

The country, which finds itself in the second half of the pandemic, hopes to count 10 million of Pfizer’s dose, another 10 million of the Chinese company Sinovac and 6 million of Astrazeneca.

Similarly, Costa Rica has received from December 23 five Pfizer vacancies for a total of 104,325 units, of which 25 have applied 45,707 primary doses and 2,421 correspondents to the second.

Pesar de buen aranque en el chronogram de vacunación, la pharmacutica suspendi las entregas debido a ajustes en su manufactura, pero las reanudará el 15 februari y couplirá con la cantidad acordada en el primer trimester del año.

Costa Rica, with 5 million residents, acquired by Pfizer 3 million doses, shipped to 1.5 million residents, means that with the AstraZeneca inoculated to 500,000 residents there is one million with those that the Covax mechanism, of the World Health Organization (OMS).

For its part, Ecuador on January 21st hosted a “pilot phase” in which it will administer 8,000 vacancies for sanitary workers, major adults and geriatric staff.

This lot is part of a first installment of 86,000 doses negotiated with Pfizer, which will add up to 2 million.

Additionally, Gobierno negotiated a 5 million dose with AstraZeneca, 4 million with the Covaxx company and another 8 million with the Covax mechanism.

Meanwhile, Panama is starting the 20th of January on its immunization campaign to receive its first Pfizer remnant with 12,840 doses, reduced by production problems, which is 40,000.

EL GIGANTE QUE CAMINA LENTO

Brazil, criticized by the alleged initiation of the evacuation, has imported from India 2 million doses of AstraZeneca and has an increase of 10 million more than Sinovac, figures that result in insufficient to protect and its 212 million inhabitants.

The controversy erupted in October of last year when President Jair Bolsonaro resigned over the purchase of Chinese vacancies from Sinovac and was disqualified from his minister of health, Eduareo Pazuello, who announced the 46-million-dollar deal.

According to Bolsonaro, there was a failure of the Chinese immunization force, it was reported that it was developed and experimented in Brazil in association with the Butantan Institute, a scientific institution located in the state of Sao Paulo, with Governor Joao Doria, mededinger político del presidente.

In exchange, on the other hand, there are residents of China’s strongholds in Peru, who are preparing to pay fines of the first lot of one million vacancies required at the Sinopharm laboratory of a total of 38 million.

However, the General Directorate of Medicines, Substances and Drugs, however, has already obtained the authorization of its entry and, as indicated, hopes that Sinopharm will establish “key documents” regarding certification and operation of its laboratory in Beijing.

PREFERENCE FOR LOS RUSOS

Another option is that in the United States, Latin America is taking action against the aggressive coronavirus and the Russian Sputnik V vaccine.

Here is the confirmation from Argentina, which claims to have immunized up to 10 million people with the preparation of the first collection of 300,000 doses by December 25 with those who have been evacuated to sanitary personnel.

Another case is that of Bolivia, which signed a contract to acquire 5.2 million doses, with a first deposit of 1.7 million in March next and other successive ones in April and May.

The first lot of 6, .000 vacancies against the covid-19 of Russian manufacturing for Bolivia is in the pipeline, informs this Wednesday the Ministry of External Relations of the Netherlands.

In the middle of this month, Gobierno signed another contract for the donation of 5 million AstraZeneca vacancies and to cover the “100%” population ready to be vaccinated by April.

As if to hope for political certainty, Venezuelan Govierno Nicolás Maduro announced on December 29 an agreement with Russia to buy Sputnik V for 10 million to pretend to be evacuating its residents during the first quarter.

All this in the middle of a controversy: Maduro corrected the March passed on his assertion that the pharmacy Carvativir “neutralizes to 100%” in covid-19 and indicates that the product hecho in the Caribbean country is “complementary” in the air against the enfermedad, for that matter, at the moment, Venezuelans are being exposed to viruses.

WITH NO COMMENT ON VACANCY

One step further is Colombia, where Gobierno has agreed with Covax to acquire 20 million doses, in addition to 10 million from Pfizer, 10 million from AstraZeneca and 9 million from Belgian Janssen, a subsidiary of the Johnson & Johnson branch and each preparation requires a sole application, but has not received a sole of them.

In the case of Uruguay, it was announced that all of its staff would be evacuated in three days, the first 200,000 units of the 2,000,700 that were negotiated with Pfizer, and the 1,750,000 units of Sinovac.

On the other hand, in El Salvador there is no exact charge for inoculation with 2 million doses of AstraZeneca and in the Dominican Republic the expectant is that in March there was an increase in the 7.9 million doses of Pfizer and 10 million of AstraZeneca negotiated .

CUBA AND COVAX, THE EXPERIENCE OF THE POWERS

While in some Latin American countries the Governors revise their bolsillos to find money and buy vacancies, Cuba initiates the 18th of a new phase of clinical trials of Soberana 02, the most advanced of its four candidates to immunize man queoja.

Cuba has a renowned biotechnology and pharmaceutical industry that currently produces vaccines against meningitis, pulmonary cancer and solid tumors, among others.

The island is waking up to an “important part” of its population in anticipation of the first semester of 2021, when it opens the door to other economic resources that can pursue biology.

An urgent notice in this regard also states that there are more than 280 million dosing vacancies in Latin America this year under the Covax program, in agreement with the Alliance for GAVI Vacancies.

Although it does not specify which countries, subject to the World Bank classification by GAVI and the OMS use to design the beneficiaries of Covax, treaties of El Salvador, Honduras, Nicaragua, Bolivia and Haiti.

.Source